Høj forekomst af endemisk HVC-infektion, fortsat smitteoverførsel blandt intravenøse stofbrugere, med en stigende forekomst registreret blandt nogle grupper, og en stor højrisikogruppe af intravenøse
High levels of endemic HCV infection, continued transmission among drug injectors, with increased incidence observed in some groups, and a large high-risk group of injectors in some of the new Member States all speak of the need to continue to regard drug injection, and its associated health problems, as a major public health issue in Europe and a critical area for drug policy and research vigilance.